MEI Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Justin J. File, with a market cap of $42.5M.
Common questions about MEI Pharma
MEI Pharma is scheduled to report earnings for Q3 2026 on May 12, 2026.
MEI Pharma has approximately 28 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.